[1] |
张秋学,赵连利,刘汝海,等.肝门胆管癌术后胆道系统并发症的防治[J].中华肝胆外科杂志,2014, 20(6):440-442.
|
[2] |
Zaydfudim VM, Rosen CB, Nagorney DM, et al. Hilar cholangiocarcinoma[J]. Surg Oncol Clin N Am, 2014, 23(2):247-263.
|
[3] |
王坚.Bismuth Ⅳ型肝门胆管癌的治疗[J].肝胆胰外科杂志,2015, 27(6):441-444.
|
[4] |
李景林,姜兴明,冷开明,等.肝门部胆管癌肝切除范围的变化[J].中华普通外科杂志,2017, 32(12):1077-1079.
|
[5] |
Murakami S, Ajiki T, Ueno K, et al. Curative resection of hilar cholangiocarcinoma in a 25-year-old woman: report of a case[J]. Surgery today, 2014, 44(7):1350-1354.
|
[6] |
陈孝平,项帅.精准医学时代肝门部胆管癌的治疗[J].中华消化外科杂志,2018, 17(1):3-8.
|
[7] |
Chen W, Ke K, Chen YL, et al. Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis[J]. Eur J Surg Oncol, 2014, 40(5):489-495.
|
[8] |
彭承宏,邓侠兴,张天.肝门胆管癌手术中的关键技术[J].肝胆外科杂志,2014, 22(5):321-322, 370.
|
[9] |
谢应海,王琦,李瑞,等.经皮肝穿刺胆管腔内射频消融联合植入支架治疗肝门胆管癌伴恶性梗阻临床疗效研究[J].临床军医杂志,2017, 45(9):894-897.
|
[10] |
李可为,施维锦.肝门胆管癌的姑息性治疗[J].肝胆胰外科杂志,2015, 27(6):445-449.
|
[11] |
Welling TH, Feng M, Wan S, et al. Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma[J]. Liver Transpl, 2014, 20(1):81-88.
|
[12] |
Feo CF, Ginesu GC, Barmina M, et al. Curative resection for hilar cholangiocarcinoma: single-center experience with long-term follow-up[J]. Am Surg, 2018, 84(1):9-10.
|
[13] |
Chen Y, Liu Z, Duan W, et al. Modified arterioportal shunting in radical resection of hilar cholangiocarcinoma[J]. Hepatogastroenterology, 2014, 61(129):9-11.
|
[14] |
董家鸿,项灿宏,石军,等.以围肝门切除为本的肝门部胆管癌治愈性切除术的临床疗效[J].中华消化外科杂志,2017, 16(10):1053-1060.
|
[15] |
Yoo T, Park SJ, Han SS, et al. Proximal resection margins: more prognostic than distal resection margins in patients undergoing hilar cholangiocarcinoma resection[J]. Cancer Res Treat, 2018, 50(4): 1106-1113.
|
[16] |
Chen YT, Yao HR, Xu LF, et al. Hepatic arterial infusion chemotherapy combined with endogenetic hyperthermia treatment of hilar cholangiocarcinoma[J]. Hepatogastroenterology, 2014, 61(129):151-155.
|
[17] |
Zhang XF, Squires MH, Bagante F, et al. The impact of intraoperative re-resection of a positive bile duct margin on clinical outcomes for hilar cholangiocarcinoma[J]. Ann Surg Oncol, 2018, 25(5):1140-1149.
|
[18] |
王冬冬,孙万亮,鲁正,等.ⅢⅣ型肝门部胆管癌扩大肝切除临床疗效分析[J].中国肿瘤临床,2016, 43(6):250-254.
|
[19] |
黄庆国,朱载阳,李鹏泽.扩大肝切除术治疗Ⅲ至Ⅳ期肝门部胆管癌的临床价值[J].癌症进展, 2017, 15(3):325-327.
|
[20] |
Gomez D, Patel PB, Lacasia-Purroy C, et al. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma[J]. Eur J Surg Oncol, 2014, 40(1):77-84.
|